|
|
Article: Addition of ADVEXIN(R) to Chemotherapy Shows Promise in Treating Locally Advanced Breast Cancer.
- Article from:
- PR Newswire
- Article date:
- December 9, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Combination Neoadjuvant Therapy Resulted in 100 Percent Tumor Response and Complete Surgical Removal -
Introgen Therapeutics, Inc. reported data from its Phase 2 trial evaluating ADVEXIN(R) combined with neoadjuvant chemotherapy in women with locally advanced breast cancer. Neoadjuvant treatments are administered prior to surgery and represent a novel and increasingly applied approach to make surgical tumor resections either more complete improving outcomes or less invasive facilitating breast conservation. Objective clinical responses with a greater than 50 percent reduction in tumor size were seen following the combined therapy in all of the patients. ...